As­traZeneca names con­tro­ver­sial can­cer sci­en­tist José Basel­ga to a top R&D post in ma­jor shake­up

Just days af­ter Bahi­ja Jal­lal an­nounced her de­ci­sion to leave her post at the top of As­traZeneca’s big bi­o­log­ics sub­sidiary Med­Im­mune and take the helm at Im­muno­core, the phar­ma gi­ant is shak­ing up its R&D lead­er­ship and bring­ing in a con­tro­ver­sial new head of on­col­o­gy R&D.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER